Free Trial

CorMedix (CRMD) News Today

CorMedix logo
$10.33 -0.48 (-4.44%)
Closing price 04:00 PM Eastern
Extended Trading
$10.33 +0.00 (+0.04%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why Is CorMedix Dropping Today?

CorMedix Inc. (NASDAQ: CRMD) saw its stock rise today, driven by strong Q2 earnings results and the strategic Melinta Therapeutics acquisition. Here’s what’s moving CRMD shares:

  • Positive Sentiment: CorMedix surpassed Q2 2025 earnings and revenue estimates, reporting $0.28 EPS vs. $0.20 expected and $39.74 M in revenue vs. $29.88 M consensus Zacks
  • Positive Sentiment: CorMedix announced acquisition of Melinta Therapeutics for $300 million, adding six marketed infectious-disease products and targeting double-digit EPS accretion in 2026 WSJ
  • Neutral Sentiment: Q2 2025 earnings call transcript highlighted pipeline progress and financial guidance Seeking Alpha
  • Neutral Sentiment: Unusually high trading volume observed, indicating increased market interest MarketBeat
  • Neutral Sentiment: Analysts maintain an average target price of $17.14 for CRMD AmericanBankingNews
  • Neutral Sentiment: CorMedix is expected to announce Q2 earnings before market open on August 13 MarketBeat
  • Negative Sentiment: HC Wainwright lowered CRMD’s price target from $20 to $17, despite maintaining a buy rating Benzinga
Posted 2h agoAI Generated. May Contain Errors.

CRMD Latest News

CorMedix (CRMD) Expected to Announce Earnings on Wednesday
HC Wainwright Estimates CorMedix FY2027 Earnings
CorMedix Seems Significantly Undervalued
CorMedix (NASDAQ:CRMD) Shares Gap Down - Here's Why
CorMedix announces customer implementation
CorMedix Inc. (CRMD): A Bull Case Theory
CorMedix Inc. (CRMD): A Bull Case Theory
CorMedix inc. Announces Customer Implementation
Get CorMedix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter.

CRMD Media Mentions By Week

CRMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRMD
News Sentiment

0.52

0.38

Average
Medical
News Sentiment

CRMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRMD Articles
This Week

11

5

CRMD Articles
Average Week

Get CorMedix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CRMD) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners